PhD. Topics
Institute of Neuroimmunology
- Analysis of tau proteins in clinical samples
- Development nanodrug system against neurotropic flavivirus
- Changes in neuronal activity in disorders of the brain. What distinguishes healthy and diseased brains?
- Changes in neuronal activity in disorders of the brain. What distinguishes healthy and diseased brains?
- Identification of dysregulated signaling pathways in animal model of neurodegeneration
- Identification of novel interaction partners of physiological and pathological tau protein that may serve to develop therapeutic approaches for the treatment of Alzheimer's disease.
- Identification of novel interaction partners of physiological and pathological tau protein that may serve to develop therapeutic approaches for the treatment of Alzheimer's disease.
- Identification of novel interaction partners of physiological and pathological tau protein that may serve to develop therapeutic approaches for the treatment of Alzheimer's disease.
- Identification of novel interaction partners of physiological and pathological tau protein that may serve to develop therapeutic approaches for the treatment of Alzheimer's disease.
- Immunophenotyping of B- cells induced by vaccination: markers of immunity
- Integrative application of structural biology methods for the study of physiological and pathological tau protein conformations
- Integrative application of structural biology methods for the study of physiological and pathological tau protein conformations
- Markers of functional immune response of T-lymphocytes suitable for characterization of primary and secondary immunodeficiencies
- Molecular basis of the interaction of tau proteins with heparan sulphate proteoglycans
- Molecular basis of the interaction of tau proteins with heparan sulphate proteoglycans
- Non-pharmacological interventions in animal models for Alzheimer’s disease and other tauopathies.
- Non-pharmacological interventions in animal models for Alzheimer’s disease and other tauopathies.
- Novel receptor-mediated delivery system for brain therapeutics
- Novel receptor-mediated delivery system for brain therapeutics
- Novel receptor-mediated delivery system for brain therapeutics
- Novel receptor-mediated delivery system for brain therapeutics
- Prediction of novel biomarkers and characterization of signaling pathways of traumatic brain injury.
- Structural pathways that transferrins use for fibrinolysis regulation
- Structure analysis of the innate immune response mediated by lactoferrin
- Study of the impact of heatstroke on the function of CNS cells
- Study of the impact of microplastics on cells of the neurovascular unit of the brain
- The effect of glial cells on tau spreading in neuro-glia cell-based model for Alzheimer’s disease
- The effect of glial cells on tau spreading in neuro-glia cell-based model for Alzheimer’s disease
- The effect of glial cells on tau spreading in neuro-glia cell-based model for Alzheimer’s disease
- The role of high-calorie diet in neurodegeneration. Impact on tau neurofibrillary pathology and microbiome.